Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females



      To estimate the prevalence of past year laxative use or vomiting weight control behaviors among adolescent females in the general population and to examine the relationship between these behaviors and substance use among adolescent females, with a specific focus on past year 3–4 methylenedioxymethamphetamine (MDMA) (“Ecstasy”) use.


      Secondary analyses were conducted using a nationally representative sample of females aged 12 to 17 years (n = 4292) from the 2001 National Household Survey on Drug Abuse (NHSDA). Logistic regression was used to examine bivariate relationships between past year laxative use or vomiting weight control behaviors and substance use and the multivariate relationship between unhealthy weight control behaviors and Ecstasy use.


      Approximately 10% of adolescent females had used laxatives or vomited to lose weight in the past year. Adolescent females who had used laxatives or vomited to lose weight in the past year were more likely than those who had not to have used substances during the past year, including Ecstasy, inhalants, nonmedical psychotherapeutics, marijuana, cigarettes, and alcohol. After controlling for demographics and other substance use, past year laxative use or vomiting weight control behaviors were positively associated with past year Ecstasy use (OR = 1.81; 95% CI = 1.05, 3.14; p = 0.04).


      Laxative use or vomiting weight control behaviors are a significant problem among the general population of adolescent females and are related to an increased risk of Ecstasy use.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Adolescent Health
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Croll J.
        • Neumark-Sztainer D.
        • Story M.
        • et al.
        Prevalence and risk and protective factors related to disordered eating behaviors among adolescents.
        J Adolesc Health. 2002; 31: 166-175
        • Grigg M.
        • Bowman J.
        • Redman S.
        Disordered eating and unhealthy weight reduction practices among adolescent females.
        Prev Med. 1996; 25: 748-756
        • Neumark-Sztainer D.
        • Story M.
        • Falkner N.H.
        • et al.
        Sociodemographic and personal characteristics of adolescents engaged in weight loss and weight/muscle gain behaviors.
        Prev Med. 1999; 28: 40-50
        • Phelps L.
        • Andrea R.
        • Rizzo F.G.
        • et al.
        Prevalence of self-induced vomiting and laxative/medication abuse among female adolescents.
        Int J Eat Disord. 1993; 14: 375-378
      1. Centers for Disease Control and Prevention. Surveillance summaries, June 28, 2002. MMWR 2002;51(SS-4).

        • Hsu L.K.
        Epidemiology of the eating disorders.
        Psychiatr Clin North Am. 1996; 19: 681-700
        • Kotler L.
        • Cohen P.
        • Davies M.
        • et al.
        Longitudinal relationships between childhood, adolescent, and adult eating disorders.
        J Am Acad Child Adolesc Psychiatry. 2001; 40: 1434-1440
        • Kreipe R.E.
        • Birndorf S.A.
        Eating disorders in adolescents and young adults.
        Med Clin North Am. 2000; 84: 1027-1049
        • Pritts S.D.
        • Susman J.
        Diagnosis of eating disorders in primary care.
        Am Fam Physician. 2003; 67: 297-304
        • Golden N.H.
        • Katzman D.K.
        • Kreipe R.E.
        • et al.
        Eating disorders in adolescents.
        J Adolesc Health. 2003; 33: 496-503
        • Holderness C.C.
        • Brooks-Gunn J.
        • Warren M.P.
        Co-morbidity of eating disorders and substance abuse.
        Int J Eat Disord. 1994; 16: 1-34
        • O’Brien K.M.
        • Vincent N.K.
        Psychiatric comorbidity in anorexia and bulimia nervosa.
        Clin Psychol Rev. 2003; 23: 57-74
        • Lowry R.
        • Galuska D.A.
        • Fulton J.E.
        • et al.
        Weight management goals and practices among U.S. high school students.
        J Adolesc Health. 2002; 31: 133-144
        • Neumark-Sztainer D.
        • Story M.
        • Dixon L.B.
        • et al.
        Adolescents engaging in unhealthy weight control behaviors.
        Am J Public Health. 1998; 88: 952-955
        • Stock S.L.
        • Goldberg E.
        • Corbett S.
        • et al.
        Substance use in female adolescents with eating disorders.
        J Adolesc Health. 2002; 31: 176-182
        • Swanston H.Y.
        • Plunkett A.M.
        • O’Toole B.I.
        • et al.
        Nine years after child sexual abuse.
        Child Abuse Negl. 2003; 27: 967-984
        • The McKnight Investigators
        Risk factors for the onset of eating disorders in adolescent girls.
        Am J Psychiatry. 2003; 160: 248-254
        • Becker A.E.
        • Grinspoon S.K.
        • Klibanski A.
        • et al.
        Eating disorders.
        N Engl J Med. 1999; 340: 1092-1098
      2. Substance Abuse and Mental Health Services Administration [publication on the Internet]. Rockville, MD: The NHSDA Report: Ecstasy use [updated 2003 May 19; cited 2004 Jun 23] Available from:

        • Parrott A.C.
        • Buchanan T.
        • Scholey A.B.
        • et al.
        Ecstasy/MDMA attributed problems reported by novice, moderate, and heavy recreational users.
        Hum Psychopharmacol. 2002; 17: 309-312
        • Murray J.B.
        Ecstasy is a dangerous drug.
        Psychol Rep. 2001; 88: 895-902
        • Yacoubian G.S.
        Correlates of ecstasy use among high school seniors surveyed through Monitoring the Future.
        Drugs Educ Prev Policy. 2003; 10: 65-72
        • Henry J.A.
        Ecstasy and the dance of death.
        BMJ. 1992; 305: 5-6
        • Randall T.
        Rave scene, ecstasy use, leap Atlantic.
        JAMA. 1992; 268: 1506
        • Strote J.
        • Lee J.E.
        • Wechsler H.
        Increasing MDMA use among college students.
        J Adolesc Health. 2002; 30: 64-72
        • Reneman L.
        • Booij J.
        • de Bruin K.
        • et al.
        Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
        Lancet. 2001; 358: 1864-1869
        • Verheyden S.L.
        • Hadfield J.
        • Calin T.
        • et al.
        Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, “ecstasy”) on mood.
        Psychopharmacology (Berl). 2002; 161: 23-31
        • Liechti M.E.
        • Gamma A.
        • Vollenweider F.X.
        Gender differences in the subjective effects of MDMA.
        Psychopharmacology (Berl). 2001; 154: 161-168
      3. Substance Abuse and Mental Health Services Administration. Results from the 2001 National Household Survey on Drug Abuse. 2002 (Rockville, MD)
        • U.S. Department of Health and Human Services
        Substance Abuse and Mental Health Services Administration.
        Office of Applied Studies. National Household Survey on Drug Abuse, 2001 [Computer file]. ICPSR version. Rockville, MD. Inter-university Consortium for Political and Social Research [distributor], Ann Arbor, MI2002
        • Research Triangle Institute
        SUDAAN (Release 8.0).
        (computer software) Research Triangle Institute, Research Triangle Park, NC2002
        • DuRant R.H.
        • Smith J.A.
        • Kreiter S.R.
        • et al.
        The relationship between early age of onset of initial substance use and engaging in multiple health risk behaviors among young adolescents.
        Arch Pediatr Adolesc Med. 1999; 153: 286-291
        • Green A.R.
        • Cross A.J.
        • Goodwin G.M.
        Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”).
        Psychopharmacology (Berl). 1995; 119: 247-260
        • Ropero-Miller J.D.
        • Goldberger B.A.
        Recreational drugs.
        Clin Lab Med. 1998; 18: 727-746
        • Gerhard H.
        Int J Clin Pharmacol Ther. 2001; 39: 362-366
        • Champion S.
        Fit for anything.
        The Guardian. 1993 (December 4.)
        • Morral A.R.
        • McCaffrey D.F.
        • Chien S.
        Measurement of adolescent drug use.
        J Psychoactive Drugs. 2003; 35: 301-309
        • Johnston L.D.
        • O’Malley P.M.
        • Bachman J.G.
        The Monitoring the Future National Results on Adolescent Drug Use.
        (NIH Publication No. 02–5105) National Institute on Drug Abuse, Rockville, MD2002